Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis

Persu, A. et al. (2018) Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis. Journal of Hypertension, 36(2), pp. 221-229. (doi:10.1097/HJH.0000000000001582) (PMID:29045339)

150256.pdf - Accepted Version



Background: Sympathetic tone is one of the main determinants of blood pressure (BP) variability and treatment-resistant hypertension. The aim of our study was to assess changes in BP variability after renal denervation (RDN). In addition, on an exploratory basis, we investigated whether baseline BP variability predicted the BP changes after RDN. Methods: We analyzed 24-h BP recordings obtained at baseline and 6 months after RDN in 167 treatmentresistant hypertension patients (40% women; age, 56.7 years; mean 24-h BP, 152/90 mmHg) recruited at 11 expert centers. BP variability was assessed by weighted SD [SD over time weighted for the time interval between consecutive readings (SDiw)], average real variability (ARV), coefficient of variation, and variability independent of the mean (VIM). Results: Mean office and 24-h BP fell by 15.4/6.6 and 5.5/ 3.7 mmHg, respectively (P < 0.001). In multivariable-adjusted analyses, systolic/diastolic SDiw and VIM for 24-h SBP/DBP decreased by 1.18/0.63 mmHg (P 0.01) and 0.86/0.42 mmHg (P 0.05), respectively, whereas no significant changes in ARV or coefficient of variation occurred. Furthermore, baseline SDiw (P ¼ 0.0006), ARV (P ¼ 0.01), and VIM (P ¼ 0.04) predicted the decrease in 24-h DBP but not 24-h SBP after RDN. Conclusion: RDN was associated with a decrease in BP variability independent of the BP level, suggesting that responders may derive benefits from the reduction in BP variability as well. Furthermore, baseline DBP variability estimates significantly correlated with mean DBP decrease after RDN. If confirmed in younger patients with less arterial damage, in the absence of the confounding effect of drugs and drug adherence, baseline BP variability may prove a good predictor of BP response to RDN.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Mark, Dr Patrick
Authors: Persu, A., Gordin, D., Jacobs, L., Thijs, L., Bots, M. L., Spiering, W., Miroslawska, A., Spaak, J., Rosa, J., de Jong, M. R., Berra, E., Fadl Elmula, F. E. M., Wuerzner, G., Taylor, A. H.M., Olszanecka, A., Czarnecka, D., Mark, P. B., Burnier, M., Renkin, J., Kjeldsen, S. E., Widimský, J., Elvan, A., Kahan, T., Steigen, T. K., Blankestijn, P. J., Tikkanen, I., and Staessen, J. A.
Subjects:R Medicine > RC Internal medicine
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of Hypertension
Publisher:Lippincott Williams & Wilkins
ISSN (Online):1473-5598
Published Online:16 October 2017
Copyright Holders:Copyright © 2017 Wolters Kluwer Health, Inc.
First Published:First published in Journal of Hypertension 36(2):221-229
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record